Journals / Turkish Neurosurgery / 2011 / Cilt: 21 - Sayı: 3

Tirotropin sekrete eden pituiter adenoma eşlik eden sessiz somatotropinoma

Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma

Pages
403–407
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, we always recommend hormonal examinations for all patients who have pituitary adenoma without signs and symptoms of acromegaly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thyroid stimulating hormone (TSH) secreting pituitary adenomas are rare tumors manifested as hyperthyroidism with goiter in the presence of elevated TSH.
📊
Key Findings & Data:After two years of the treatment, tumor size remained the same while thyroid function tests and insulin-like growth factor 1 (IGF-I) values returned to normal ranges.
💡
Conclusion & Impact:In conclusion, we always recommend hormonal examinations for all patients who have pituitary adenoma without signs and symptoms of acromegaly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Thyroid stimulating hormone (TSH) secreting pituitary adenomas are rare tumors manifested as hyperthyroidism with goiter in the presence of elevated TSH. We present a case with pituitary adenoma secreting both TSH and growth hormone (GH) with the prominent clinical findings of hyperthyroidism but without clinical findings of acromegaly. Pituitary magnetic resonance imaging revealed a macroadenoma. Transsphenoidal surgery was performed twice. The immunohistochemical staining showed that tumor cells were strongly reactive to GH and relatively mildly reactive to TSH. Control pituitary imaging revealed a residual macroadenoma, and long acting octreotide treatment was administered. After two years of the treatment, tumor size remained the same while thyroid function tests and insulin-like growth factor 1 (IGF-I) values returned to normal ranges. In conclusion, we always recommend hormonal examinations for all patients who have pituitary adenoma without signs and symptoms of acromegaly.

Özet

Tiroid stimule edici hormon (TSH) salgılayan pituiter adenomlar yüksek TSH seviyeleri ile birlikte hipertiroidi ve guatrın görüldüğü nadir tümörlerdir. Akromegali klinik bulgularının görülmediği, ön planda hipertiroidi kliniğinin yer aldığı TSH ve büyüme hormonu (GH) salgılayan piuiter adenomlu bir vakayı sunuyoruz. Pituiter manyetik rezonans görüntülemede makroadenom tespit edilerek iki defa transsfenoidal cerrahi uygulandı. İmmünhistokimyasal incelemede güçlü bir şekilde GH ve daha az oranda TSH ile boyanma izlendi. Kontrol pituiter görüntülemesinde rezidü makroadenom görülmesi nedeniyle uzun etkili oktreotid başlandı. İki yıllık tedavi sonrasında tümor boyutu sabit kalırken tiroid fonksiyon testleri ve insulin benzeri büyüme faktörü 1 (IGF-I) düzeyleri normale döndü. Sonuç olarak akromegali klinik bulguları olmasa dahi her zaman pitüiter adenomu olan hastaların değerlendirilmesinde hormonal incelemelerin yapılmasını öneriyoruz.

🔖

Cite This Article

BERKER, D., IŞIK, S., AYDIN, Y., TÜTÜNCÜ, Y., AKDEMİR, G., ÖZCAN, H. N., GÜLER, S. (2011). Tirotropin sekrete eden pituiter adenoma eşlik eden sessiz somatotropinoma. Turkish Neurosurgery, Cilt: 21 - Sayı: 3, 403–407. https://ajindex.com/articles/417773

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Andersen M, Hagen C, Frystyk J, Schroeder H, Hagen C: Development of acromegaly in patients with prolactinomas. Eur J Endocrinol 149:17-22, 2003 2. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD: Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610-638, 1996 3. Beck-Peccoz P, Persani L: Medical management of thyrotropinsecreting pituitary adenomas. Pituitary 5:83-88, 2002 4. Beck-Peccoz P, Piscitelli G, Amr S, Ballabio M, Bassetti M, Giannattasio G, Spada A, Nissim M, Weintraub BD, Faglia G: Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: Evidence for secretion of TSH with increased bioactivity. J Clin Endocrinol Metab 62:704-711, 1986 5. Chanson P, Weintraub BD, Harris AG: Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119:236-240, 1993 6. Felix I, Asa SL, Kovacs K, Horvath E, Smyth HS: Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin. Arch Pathol Lab Med 118:66-70, 1994 7. Holdaway IM, Rajasoorya C: Epidemiology of acromegaly. Pituitary 2:29-41, 1999 8. Jailer Jw, Holub Da: Remission of Graves’ disease following radiotherapy of a pituitary neoplasm. Am J Med 28:497-500, 1960 9. Klibanski A, Zervas NT, Kovacs K, Ridgway EC: Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg 66:806-811, 1987 10. Kovacs K, Lloyd R, Horvath E, Asa SL, Stefaneanu L, Killinger DW, Smyth HS: Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 134: 345-353, 1989 11. Lee EJ, Kim KR, Lee KM, Yoon DH, Kim YS, Kim DI, Jung WH, Chung YS, Lim SK, Lee HC, Huh KB: Thyrotropin-secreting pituitary microadenoma. Yonsei Med J 33:368-373, 1992 12. Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P: Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81:3084-3090, 1996 13. Pestell R, Herington A, Best J, Boolell M, McKelvie P, Arnott R, Alford F: Growth hormone excess and galactorrhoea without acromegalic features. Case reports. Br J Obstet Gynaecol 98:92-97, 1991 14. Sen O, Ertorer ME, Aydin MV, Erdogan B, Altinors N, Zorludemir S, Guvener N: Silent pituit